High-intensity focused ultrasound used to identify stroke biomarkers
A molecule called glial fibrillary acidic protein (GFAP) rose significantly in the blood of patients who underwent ...
Voyager Therapeutics announces data from SAD trial of VY7523
Voyager Therapeutics (VYGR) announced positive topline data from the Company’s single ascending dose, SAD, trial of VY7523, an investigational ...
The Brighterside of News on MSN1d
Major new study identifies key protein driving Alzheimer’s disease
Alzheimer’s disease, a devastating neurodegenerative disorder, is closely linked to the accumulation of tau protein in the ...
Alector, Inc. (ALEC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET. Company Participants. Katie Hogan - Senior Director-Corporate Communications and Investo ...
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025Anticipate completing enrollment in ...
Hosted on MSN6d
For Your Patients: Navigating Treatment Options in Early Stage Alzheimer’s Disease
With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...